Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunobinop for Alcohol Craving in Alcohol Use Disorder
NCT06545929Phase 2Completed
- Sponsor
- Knoa Pharma
- Start
- Jan 2025
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sunobinop in alcohol use disorder (AUD), sponsored by Knoa Pharma. Started Jan 2025; status: completed.
02
Drugs
sunobinop
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT06545929.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06545929.